RAPP
Rapport Therapeutics
RAPP
RAPP
142 hedge funds and large institutions have $1.55B invested in Rapport Therapeutics in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $1.46B → $1.55B (+$86.4M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
27.83% less ownership
Funds ownership: 135.01% → 107.18% (-28%)
Holders
142
Holding in Top 10
5
Calls
$834K
Puts
$519K
Top Buyers
| 1 | +$23.9M | |
| 2 | +$16M | |
| 3 | +$9.5M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$7.47M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$7.06M |
Top Sellers
| 1 | -$9.55M | |
| 2 | -$9.18M | |
| 3 | -$8.3M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.44M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.11M |
